KYLE MANCUSO: Open Payments
NPI 1861175820 · PORT ALLEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 68 payments from 14 companies in 2025. Trend: 2023 $165 · 2024 $910 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $171 |
| Novo Nordisk Inc | 11 | $169 |
| PFIZER INC. | 9 | $146 |
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| Lilly USA, LLC | 5 | $93 |
| Phathom Pharmaceuticals, Inc. | 8 | $77 |
| Abbott Laboratories | 2 | $60 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: VRAYLAR, MOUNJARO, PREVNAR 20, VOQUEZNA, AIRSUPRA, Wegovy, BREZTRI, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
